ERYTHROCIN INTRAMAMMARY SOLUTION 300MG
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
03-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ERYTHROMYCIN
Available from:
Ceva Animal Health Limited
ATC code:
QJ51FA01
Dosage:
300 Milligram
Pharmaceutical form:
intramammary Solution
Therapeutic group:
Antibacterial
Therapeutic area:
Bovine
Authorization date:
1988-10-01
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995
MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998
(S.I. NO.142 OF 1998)
10995/010/001
Case No: 7002385
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
CEVA ANIMAL HEALTH LIMITED
90 THE BROADWAY, CHESHAM, BUCKS HP15 1EG, UNITED KINGDOM
an authorisation, subject to the provisions of the said Regulations, in respect of the product
ERYTHROCIN INTRAMAMMARY SOLUTION 300MG
The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as
may be specified in the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 15/12/2006 until .
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 17/12/2006_
_CRN 7002385_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Erythrocin Intramammary Solution 300mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Intramammary solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of clinical and subclinical mastitis in cattle due to erythromycin-sensitive:
_Staphlococcus aureus_
_Streptococcus agalactia_
_S. dysgalactia_
_S. uberis_
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
None.
Each 6ml syringe contains :
Active substance
Er
Read the complete document
